Company Profiles

driven by the PitchBook Platform

Ablatus Therapeutics

Description

Developer of a medical devices designed to use innovative ablation technology for the treatment of solid tumours. The company's medical devices help to use novel tissue ablation technology that destroy tissue, such as a tumour and offers the potential to address some of the problems of the most commonly-used ablation system, enabling patients to limit the size of tumours that can be effectively treated with RFA.

2015

Founded

PRIVATE

Status

1-10

Employees

Seed

Latest Deal Type

$658k

Latest Deal Amount

$658k

Total Amount Raised

Description

Developer of a medical devices designed to use innovative ablation technology for the treatment of solid tumours. The company's medical devices help to use novel tissue ablation technology that destroy tissue, such as a tumour and offers the potential to address some of the problems of the most commonly-used ablation system, enabling patients to limit the size of tumours that can be effectively treated with RFA.

Website:

www.ablatus.co.uk

Ownership Status

Privately Held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Biotechnology

Other Industries

Surgical Devices
Therapeutic Devices

Primary Office

1 Staint James Court Whitefriars Norwich NR3 1RUEngland
    Request a free trial to the PitchBook Platform
    You're viewing a free company profile from the PitchBook Platform. To explore Ablatus Therapeutics's full profile, request a free trial.

    Ablatus Therapeutics Valuation and Funding

    Request access
    Deal TypeDateAmountRaised to DatePost-ValStatusStage

    Ablatus Therapeutics Investors (4)

    Request access
    Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
    Seat
    Contact
    Info
    Adapt Low Carbon GroupVenture CapitalMinority000 0000000 0000
    Anglia Capital GroupOtherMinority000 0000000 0000
    Future50Accelerator/IncubatorMinority000 0000000 0000
    New Anglia Local Enterprise PartnershipOtherMinority000 0000000 0000
    Adapt Low Carbon Group Venture Capital
    Anglia Capital Group Other
    Future50 Accelerator/Incubator
    New Anglia Local Enterprise Partnership Other

    Ablatus Therapeutics Executive Team (1)

    NameTitleBoard
    Seat
    Contact
    Info
    David Brooks Ph.DBoard Member, Executive Director and Chief Executive Officer
    David Brooks Ph.D Board Member, Executive Director and Chief Executive Officer

    Ablatus Therapeutics Board Members (3)

    NameRepresentingRoleSinceContact
    Info
    David Brooks Ph.DAblatus TherapeuticsBoard Member, Executive Director and Chief Executive Officer000 0000
    Marcus Flather MDAblatus TherapeuticsBoard Member000 0000
    William AllanSelfBoard Member000 0000
    David Brooks Ph.D Board Member, Executive Director and Chief Executive Officer Ablatus Therapeutics
    Marcus Flather MD Board Member Ablatus Therapeutics
    William Allan Board Member Self
    Request full access to PitchBook